Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy (Q30391183)

21 June 2017

title

Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy (English)

1 reference

21 June 2017

main subject

anti-retroviral agent

0 references

Anna Nilsson

1 reference

21 June 2017

Alberto Cagigi

0 references

0 references

Simone Pensieroso

1 reference

21 June 2017

Francesca Chiodi

series ordinal

1 reference

21 June 2017

publication date

1 July 2010

1 reference

Lancet Infectious Diseases

21 June 2017

published in

1 reference

21 June 2017

1 reference

21 June 2017

1 reference

21 June 2017

page(s)

499-503

1 reference

Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Class-specific antibody response to pneumococcal capsular polysaccharides in men infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

CD27: a memory B-cell marker

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Maintenance of serological memory by polyclonal activation of human memory B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

A division-linked mechanism for the rapid generation of Ig-secreting cells from human memory B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Antibody Response toHaemophilus influenzaeType b Vaccine in Relation to the Number of CD4+ T Lymphocytes in Adults Infected with Human Immunodeficiency Virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Antibodies against pneumococcal polysaccharides after vaccination in HIV-infected individuals: 5-year follow-up of antibody concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-Vi).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Compromised B cell responses to influenza vaccination in HIV-infected individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Rapid loss of specific antibodies after pneumococcal vaccination in patients with human immunodeficiency virus-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Loss of memory (CD27) B lymphocytes in HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Increased frequency of CD27- (naive) B cells and their phenotypic alteration in HIV type 1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Response of recent human immunodeficiency virus seroconverters to the pneumococcal polysaccharide vaccine and Haemophilus influenzae type b conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Duration of humoral immunity to common viral and vaccine antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

AIDS and associated malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Splenic marginal zone atrophy and progressive CD8+ T-cell lymphocytosis in HIV infection: a study of adult post-mortem spleens from Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Germinal centre CD4+ T cells are an important site of HIV replication in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

CD44 Isoforms, Including the CD44 V3 Variant, Are Expressed on Endothelium, Suggesting a Role for CD44 in the Immobilization of Growth Factors and the Regulation of the Local Immune Response

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Imaging of germinal center selection events during affinity maturation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Chemokine requirements for B cell entry to lymph nodes and Peyer's patches.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Activation-dependent modulation of B lymphocyte migration to chemokines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Increased immune activation precedes the inflection point of CD4 T cells and the increased serum virus load in human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Immunoglobulin V H 3 Gene Products: Natural Ligands for HIV gp120

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Selective deficit in antibodies specific for the superantigen binding site of gp120 in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Human Immunodeficiency Virus Type 1 TAT Protein Activates B Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

B lymphocyte dysfunctions in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Class switch recombination: a comparison between mouse and human.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

CD27(-) B-cells produce class switched and somatically hyper-mutated antibodies during chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

A new memory CD27-IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

PENTA guidelines for the use of antiretroviral therapy, 2004.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Delayed early antiretroviral treatment is associated with an HIV-specific long-term cellular response in HIV-1 vertically infected infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Kinetics of the T-cell receptor CD4 and CD8 V beta repertoire in HIV-1 vertically infected infants early treated with HAART.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Community respiratory viruses in individuals with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Influenza-associated morbidity and mortality in young and middle-aged women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Efficacy of influenza vaccination in HIV-infected persons. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

High mortality from respiratory failure secondary to swine-origin influenza A (H1N1) in South Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970117-1

7 January 2021

10.1016/S1473-3099(10)70117-1

Identifiers

DOI

1 reference

21 June 2017

1 reference